• agbiopro

UK Immune Cell Therapy Biotech Founded with €40M Series A

Updated: Jun 7, 2019

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.

7 views0 comments
Send Us a Message

Alonei Abba

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon